Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Sold by Stifel ...

Dec 28, 2024 · Stifel Financial Corp cut its stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) by 75.9% during the third quarter, according to its most recent 13F filing with …

CouponFollow Extension

9%
OFF

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Sold By Stifel ...

3 weeks from now

Dec 28, 2024 · Stifel Financial Corp cut its stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) by 75.9% during the third quarter, according to its most recent 13F filing with …

marketbeat.com

9%
OFF

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Sold By Stifel ...

3 weeks from now

Dec 28, 2024 · Stifel Financial Corp reduced its position in shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 75.9% in the 3rd quarter, HoldingsChannel reports. The …

americanbankingnews.com

9%
OFF

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Sold By Stifel ...

3 weeks from now

Dec 28, 2024 · Stifel Financial Corp cut its stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 75.9% during the third quarter, according to its most recent 13F filing with …

defenseworld.net

4%
OFF

Barclays PLC Grows Stock Position In Aquestive Therapeutics, Inc ...

3 weeks from now

16 hours ago · Barclays PLC grew its stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 285.4% during the 3rd quarter, according to its most recent Form 13F filing …

tickerreport.com

$0.13
OFF

Aquestive Therapeutics (AQST) Stock Price, News & Analysis

3 weeks from now

4 days ago · Aquestive Therapeutics, Inc. (NASDAQ:AQST) issued its quarterly earnings results on Monday, November, 4th. The company reported ($0.13) earnings per share for the quarter, …

marketbeat.com

14%
OFF

Aquestive Therapeutics Inc, AQST:NMQ Profile - FT.com

3 weeks from now

Dec 13, 2024 · Aquestive Therapeutics Inc 30 Technology Dr WARREN 07059-5166 United States USA; Phone ... Shares sold Shares held; Teachers Advisors LLC-548.55k / -73.14%: …

ft.com

$75
OFF

Aquestive Therapeutics Announces Pricing Of $75 Million …

3 weeks from now

WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing …

aquestive.com

4%
OFF

Barclays PLC Buys 73,542 Shares Of Aquestive Therapeutics, Inc.

3 weeks from now

1 day ago · Barclays PLC boosted its position in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 285.4% during the third quarter, according to the company in its most recent …

defenseworld.net

$3000
OFF

Recently Sold Homes In 07047 - 1728 Transactions - Zillow

3 weeks from now

Nov 13, 2024 · 07047 Recently Sold Homes. 1,728 results. Sort: Homes for You. 1101 92nd St, North Bergen, NJ 07047. $3,000. 3 bds; 2 ba--sqft ... Inc. are marked with the Internet Data …

zillow.com

$0.12
OFF

Aquestive Therapeutics (AQST) Earnings Date And Reports 2025

3 weeks from now

In the previous quarter, Aquestive Therapeutics (NASDAQ:AQST) missed the analysts' consensus estimate of ($0.12) by $0.01 with a reported earnings per share (EPS) of ($0.13). …

marketbeat.com

$86621
OFF

Kreg Therapeutics, Inc. Careers In North Bergen, NJ

3 weeks from now

Kreg Therapeutics, Inc. salaries in North Bergen, NJ. Salary estimated from 23 employees, users, and past and present job advertisements on Indeed. Clinic Manager. $86,621 per year. …

indeed.com

FAQs about Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Sold by Stifel ... Coupon?

How much is aquestive Therapeutics stock now?

Aquestive Therapeutics' stock was trading at $3.56 at the start of the year. Since then, AQST stock has increased by 0.0% and is now trading at $3.56. How were Aquestive Therapeutics' earnings last quarter? Aquestive Therapeutics, Inc. (NASDAQ:AQST) issued its quarterly earnings results on Monday, November, 4th. ...

How much did aquestive Therapeutics (aqst) earn in a quarter?

Aquestive Therapeutics, Inc. (NASDAQ:AQST) issued its quarterly earnings results on Monday, November, 4th. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. The firm earned $13.54 million during the quarter, compared to the consensus estimate of $12.69 million. ...

How much revenue did aquestive Therapeutics generate?

The business had revenue of $13.21 million for the quarter, compared to the consensus estimate of $11.79 million. Aquestive Therapeutics has generated ($0.14) earnings per share over the last year ( ($0.14) diluted earnings per share). ...

Should I buy Aquestive Therapeutics (AQST)?

Aquestive Therapeutics (AQST) received a Buy rating and a $4.00 price target from Wedbush analyst Andreas Argyrides today. The company’s shares opened at $0.86. Argyrides covers the Healthcare sector and focuses on stocks such as Verona Pharma, BioMarin Pharmaceutical, and Immunic. ...

How did aquestive Therapeutics perform in quarter 2024?

Aquestive Therapeutics last announced its quarterly earnings results on March 5th, 2024. The reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.04. The business had revenue of $13.21 million for the quarter, compared to the consensus estimate of $11.79 million. ...

Does aquestive therapeutics have a good news sentiment?

Aquestive Therapeutics has a news sentiment score of 1.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies. ...